October 09 – 10: The Fleming Group is organizing the CMC Analytical Comparability course, which is taking place in Vienna, Austria. Four experienced trainers present their knowledge about comparability testing methods and strategies for biological biosimilars and biobetters. Within a small group, current analytical challenges are discussed. Our Chief Business Development Officer, Markus Roucka is presenting about non-clinical strategies for characterization of biologics and the meaning of an orthogonal view. We are looking forward to meet you for intense discussions and a fruitful training.